Tag Archives: controversial

Patient receives first infusion of Biogen’s controversial Alzheimer’s drug

The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019. John Tlumacki | Boston Globe | Getty Images A 70-year-old man from Rhode Island on Wednesday was the first person to receive an infusion of Biogen‘s newly approved Alzheimer’s drug, Aduhelm, outside of a clinical trial. Marc… Read More »

UnitedHealthcare delays controversial ER policy following backlash

Dive Brief: UnitedHealthcare, the biggest private payer in the U.S., is delaying a controversial policy that could retroactively deny emergency room bills it deems non-emergent — potentially saddling patients with costly medical bills — following intense backlash from patient advocates and hospital groups. “Based on feedback from our provider partners and discussions with medical societies,… Read More »

Canadian firm works with controversial U.S. company to make ‘better’ COVID vaccine, but says Ottawa not interested

Breadcrumb Trail Links World Reopening Canada PostPandemic News National More Reopening Canada Health and Wellness Health Canadian Politics Canada ‘So far, the Canadian government hasn’t shown an inclination to talk to us about purchasing Canadian,” said Brad Sorenson, CEO of Providence Therapeutics Author of the article: Tom Blackwell Publishing date: May 25, 2021  •  1 day… Read More »

Convalescent plasma: another controversial clash of politics & science

You’d need a pretty big, stiff broom to sweep away all of the hype dished out by the Trump Administration as it announced an Emergency Use Authorization for convalescent plasma – the liquid component of blood that may be tapped for disease-fighting antibodies from people who’ve been infected with COVID-19. Before the announcement was even… Read More »